Conrad Simpfendorfer, MD

Surgeon:

No

Treats:

Adults Only

Conrad Simpfendorfer. MD, FACC, is an Interventional Cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine. He is board-certified in internal medicine, cardiovascular disease and interventional cardiology. His specialty interests include the treatment of valvular heart disease and coronary artery disease. He specializes in cardiac catheterization and coronary interventions.

A native of Chile, Dr. Simpfendorfer received his medical degree from Catholic University of Chile, in Santiago, graduating with "Unanimous Distinction." He completed his internship and residency in internal medicine at St. Luke's Hospital in Cleveland, followed by a fellowship in cardiology at Cleveland Clinic. He was appointed to Cleveland Clinic Staff in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine in 1982.

Dr. Simpfendorfer received the Distinguished Teacher Award from the Department of Cardiovascular Medicine in 1994 and from Interventional Cardiology in 2006. In 2003, Dr. Simpfendorfer received the SOLACI Award from the Latin American Society of Interventional Cardiology for his continued support of educational activities of the Society. In 2006, he was honored by the Universidad Autonoma de Mexico with the Dr. Ignacio Chavez Medal. He was named among the Best Doctors in America for 2007-2008, 2009-2010, and 2011-2012.

A frequent invited lecturer at international medical meetings, Dr. Simpfendorfer has authored more than one hundred articles and book chapters on his specialty interests. He has also served as the primary and co-investigator for numerous clinical studies related to coronary interventions.

Dr. Simpfendorfer is a Fellow of the American College of Cardiology (FACC), Fellow of the American Heart Association (FAHA), Fellow of the Society for Cardiac Angiography (FSCAI),  Fellow of the American College of Angiology,  Fellow of the Interamerican College of Physicians and Surgeons and a Fellow of the Council on Geriatric Cardiology. In addition, he is a member of the American College of Physicians and the International Andreas Gruentzig Society. He is an Honorary Member of the Cardiology Societies of Argentina, Chile, Ecuador and Peru.

Dr. Simpfendorfer was Chairman of the Cleveland Clinic International Center from 1998 to 2006, member of the Board of Governors and Board of Trustees from 2007-2010, and currently is a member of the International Leadership Board.

• Best Doctors in America, 2007-2008, 2009-2010, 2011-2012 
• Dr. Ignacio Chavez Medal, Universidad Autonoma de Mexico, 2006
• Distinguished Teacher Award, Interventional Cardiology, 2006
• SOLACI Award, Latin American Society of Interventional Cardiology, 2003
• Distinguished Teacher Award, Cardiovascular Medicine, 1994

Fellowship - Cleveland Clinic

Cardiovascular Diseases
Cleveland, OH USA
1979

Fellowship - Cleveland Clinic

Cardiology
Cleveland, OH USA
1978

Residency - Saint Luke's Medical Center

Internal Medicine
Cleveland, OH USA
1976

Internship - Saint Luke's Medical Center

Internal Medicine
Cleveland, OH USA
1974

Medical School - Catholic University Medical School

Santiago Chile
1971

• Internal Medicine
• Internal Medicine- Cardiovascular Disease

Coronary artery disease, stent restenosis, stent - coronary, cardiac catheterization, angioplasty, stent - coronary, coronary intervention

• Best Doctors in America, 2007-2008, 2009-2010, 2011-2012 
• Guest of Honor, City of Guayaquil, Ecuador, 2007
• Dr. Ignacio Chavez Medal, Universidad Autonoma de Mexico, 2006
• Distinguished Teacher Award, Section of Interventional Cardiology, Cleveland Clinic, 2005-2006
• SOLACI Award, Latinamerican Society of Interventional Cardiology, 2003
• Distinguished Teacher Award, Cardiovascular Medicine, Cleveland Clinic, 1994

• American College of Cardiology
• Society for Cardiac Angiography and Interventions
• American College of Physicians
• American Heart Association
• Society of Cardiology of Argentina, Chile, Ecuador and Peru

• Abnormal Stress Test
• Angiography
• Angioplasty
• Atherectomy
• Cardiac Catheterization
• Carotid Angiography
• Clinical Trials
• Coronary Artery Atherectomy
• Coronary Balloon Angioplasty (PTCA)
• Coronary Intervention
• C-Reactive Protein Testing
• Drug Eluting Stenting
• Electrocardiogram
• FFR determination
• General Cardiology
• Intra-aortic Balloon Pumping
• Intravascular Ultrasound
• Invasive Testing - Heart
• Pericardiocentesis
• Rotational Atherectomy
• Stress Testing
• Virtual Histology

• Angina
• Aortic Aneurysms
• Bifurcation Blockage
• Cardiac Tumors
• Coronary Artery Disease
• Heart Attack
• Ischemic Cardiomyopathy
• Restenosis
• Stent Restenosis

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/28/2012, Dr. Simpfendorfer has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

• English
• Spanish